Why did 4588.T stock fall on 13 Mar 2026?

4588.T stock fell **16.48%** mainly due to thin liquidity, sector rotation away from small-cap biotech, and market reaction to company profile coverage. Volume was **2,399,900**, below average, which amplified price movement.

What are the key financial ratios for Oncolys (4588.T)?

Oncolys shows EPS **-92.92**, PE **-30.67**, PB **18.33**, cash per share **JPY 144.67**, and a current ratio of **9.55**, indicating liquidity but ongoing negative profitability.

What near-term price levels should traders watch for 4588.T stock?

Traders should watch support at **JPY 2,500.00** and resistance near **JPY 2,668.30** (Bollinger middle). Short-term target: **JPY 2,300.00** (bear), swing target: **JPY 3,300.00** (bull, news-driven).

How does Meyka AI view 4588.T stock?

Meyka AI assigns a score of **67.86** (Grade **B**, Suggestion **HOLD**). The view balances healthy cash and R&D progress against high valuation and negative EPS; forecasts are model-based and not guarantees.

JP Stocks

Oncolys (4588.T) -16.48% to JPY 2702 on 13 Mar 2026 Mkt closed: watch catalysts

ByDanny Kontos March 13, 2026

Oncolys BioPharma Inc. (4588.T) plunged 16.48% to JPY 2,702.00 at the JPX close on 13 Mar 2026, marking it among the top losers in Tokyo. The move came on volume of 2,399,900 shares versus an average of 3,343,859, and erased a JPY 533.00 gap from yesterday’s close of JPY 3,235.00. Traders cited thin biotech liquidity and headlines summarized by Reuters as immediate context source.